Skip to main content
. Author manuscript; available in PMC: 2021 Oct 1.
Published in final edited form as: Am J Prev Med. 2020 Aug 12;59(4):570–577. doi: 10.1016/j.amepre.2020.03.026

Table 2.

Characteristics of TM and TF Study Participants With and Without at Least One Episode of Self-Harm During Follow Up (2006–2016) (N=6,327)

Participant characteristics TF (N=3,452) TM (N=2,875)

At least 1 self-harm eventa No self-harm events At least 1 self-harm eventa No self-harm events
n (%)b n (%) n (%)b n (%)
Age at index date, years
 3–17 45 (38.5) 542 (16.3) 79 (60.3) 663 (24.2)
 18–25 25 (21.4) 622 (18.7) 25 (19.1) 718 (26.2)
 26–35 15 (12.8) 577 (17.3) 15 (11.5) 689 (25.1)
 36–45 21 (18.0) 551 (16.5) 7 (5.3) 339 (12.4)
 >45 11 (9.4) 1,043 (31.3) 5 (3.8) 335 (12.2)
Race/Ethnicity
 Hispanic 22 (18.8) 682 (20.5) 31 (23.7) 466 (17.0)
 Non-Hispanic black 15 (12.8) 226 (6.8) 12 (9.2) 242 (8.8)
 Non-Hispanic white 67 (57.3) 1,755 (52.6) 74 (56.5) 1,589 (57.9)
 Other/Unknown 13 (11.1) 672 (20.2) 14 (10.7) 447 (16.3)
Study site
 KPNC 72 (61.5) 1,873 (56.2) 81 (61.8) 1,740 (63.4)
 KPGA 2 (1.7) 93 (2.8) 0 (0) 79 (2.9)
 KPSC 43 (36.8) 1,369 (41.1) 50 (38.2) 925 (33.7)
Count of mental health diagnoses at baselinec
 0 28 (23.9) 1,761 (52.8) 18 (13.7) 1,262 (46.0)
 1–2 50 (42.7) 1,153 (34.6) 60 (45.8) 1,077 (39.3)
 >2 39 (33.3) 421 (12.6) 53 (40.5) 405 (14.8)
History of suicidal ideation or self-harm at baselinec
 Yes 24 (20.5) 96 (2.9) 40 (30.5) 154 (5.6)
 No 93 (79.5) 3,239 (97.1) 91 (69.5) 2,590 (94.4)
Total 117 (3.4) 3,335 (96.6) 131 (4.6) 2,744 (95.4)
a

Includes any diagnosis of self-inflicted injury, possibly self-inflicted injury, and self-inflicted injury/poisoning.

b

Column percentages within categories, row percentages for totals.

c

Baseline refers to diagnoses or events that occurred on or before index date.

TF, transfeminine; TM transmasculine, KPNC, Kaiser Permanente Northern California, KPGA, Kaiser Permanente Giorgia, KPSC, Kaiser Permanente Southern California.